Ionis Pharmaceuticals, Inc. (IONS)
27.31
-1.02
(-3.60%)
USD |
NASDAQ |
Nov 12, 16:00
27.38
+0.07
(+0.26%)
After-Hours: 07:32
Ionis Pharmaceuticals Total Assets (Quarterly) : 2.913B for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 2.913B |
| June 30, 2026 | 2.995B |
| March 31, 2026 | 3.450B |
| December 31, 2025 | 3.524B |
| September 30, 2025 | 3.033B |
| June 30, 2025 | 2.985B |
| March 31, 2025 | 2.813B |
| December 31, 2024 | 3.004B |
| September 30, 2024 | 3.081B |
| June 30, 2024 | 2.691B |
| March 31, 2024 | 2.764B |
| December 31, 2023 | 2.990B |
| September 30, 2023 | 2.934B |
| June 30, 2023 | 2.971B |
| March 31, 2023 | 2.885B |
| December 31, 2022 | 2.534B |
| September 30, 2022 | 2.422B |
| June 30, 2022 | 2.456B |
| March 31, 2022 | 2.519B |
| December 31, 2021 | 2.612B |
| September 30, 2021 | 2.415B |
| June 30, 2021 | 2.497B |
| March 31, 2021 | 2.249B |
| December 31, 2020 | 2.390B |
| September 30, 2020 | 3.096B |
| Date | Value |
|---|---|
| June 30, 2020 | 3.079B |
| March 31, 2020 | 3.091B |
| December 31, 2019 | 3.233B |
| September 30, 2019 | 2.895B |
| June 30, 2019 | 2.878B |
| March 31, 2019 | 2.836B |
| December 31, 2018 | 2.668B |
| September 30, 2018 | 2.248B |
| June 30, 2018 | 2.247B |
| March 31, 2018 | 1.300B |
| December 31, 2017 | 1.323B |
| September 30, 2017 | 1.253B |
| June 30, 2017 | 1.091B |
| March 31, 2017 | 1.084B |
| December 31, 2016 | 912.47M |
| September 30, 2016 | 843.59M |
| June 30, 2016 | 811.11M |
| March 31, 2016 | 875.82M |
| December 31, 2015 | 956.10M |
| September 30, 2015 | 988.00M |
| June 30, 2015 | 976.26M |
| March 31, 2015 | 955.43M |
| December 31, 2014 | 955.81M |
| September 30, 2014 | 793.80M |
| June 30, 2014 | 817.78M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 7.995B |
| BridgeBio Pharma, Inc. | 2.162B |
| Biogen, Inc. | 32.05B |
| Ultragenyx Pharmaceutical, Inc. | 1.187B |
| Krystal Biotech, Inc. | 1.586B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.519B |
| Shareholders Equity (Quarterly) | 393.64M |
| Debt to Equity Ratio | 5.520 |
| Current Ratio | 5.425 |
| Net Debt Paydown Yield | -0.53% |